# Isoniazid-Related Hepatotoxicity in Clinical Practice: Incidence and Predictors

> **NCT07472348** · — · NOT_YET_RECRUITING · sponsor: **ASST Fatebenefratelli Sacco** · enrollment: 220 (estimated)

## Conditions studied

- Tuberculosis Infection
- Tuberculosis Infection, Latent

## Interventions

- **OTHER:** Standard isoniazid-based TB/LTBI therapy

## Key facts

- **NCT ID:** NCT07472348
- **Lead sponsor:** ASST Fatebenefratelli Sacco
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-05-30
- **Primary completion:** 2026-07-31
- **Final completion:** 2026-09-01
- **Target enrollment:** 220 (ESTIMATED)
- **Last updated:** 2026-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07472348

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07472348, "Isoniazid-Related Hepatotoxicity in Clinical Practice: Incidence and Predictors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07472348. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*